OncoMed Pharmaceuticals, Inc. stock price

OncoMed Pharmaceuticals, Inc. latest news:


  • 01/04/2018 14:12:25

    BRIEF-Oncomed Says Chief Executive Officer Paul Hastings Has Resigned

    Oncomed Pharmaceuticals Inc(OMED): * ONCOMED ANNOUNCES CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER PAUL J. HASTINGS HAS RESIGNED. * Oncomed Pharmaceuticals Inc(OMED) - IN INTERIM, OFFICE OF PRESIDENT WILL CONTINUE TO PERFORM DUTIES OF PRESIDENT AND CEO. * Oncomed Pharmaceuticals Inc (OMED) - BOARD OF DIRECTORS HAS APPOINTED PERRY KARSEN AS CHAIRMAN OF BOARD Source text for Eikon: Further company coverage:

  • 01/04/2018 14:11:38

    BRIEF-OncoMed Estimates 2018 Operating Cash Burn To Be Less Than $55 Mln

    Oncomed Pharmaceuticals Inc(OMED): * ONCOMED PROVIDES 2018 OUTLOOK AND 2017 YEAR-END CASH BALANCE AND ANNOUNCES AN UPDATE ON THE ROSMANTUZUMAB PROGRAM. * Oncomed Pharmaceuticals Inc(OMED) - YEAR-END 2017 CASH BALANCE OF $103.1 MILLION.

  • 11/27/2017 14:21:08

    BRIEF-Oncomed says CEO Paul Hastings to Resume Chairman of Board Responsibilities

    Oncomed Pharmaceuticals Inc(OMED): * ONCOMED - ‍CHAIRMAN, PRESIDENT, CEO PAUL HASTINGS WILL RESUME CHAIRMAN OF BOARD RESPONSIBILITIES, EFFECTIVE DEC. 4, 2017​. * ONCOMED - ‍OFFICE OF PRESIDENT WILL CONTINUE TO PERFORM DUTIES OF PRESIDENT AND CEO​ Source text for Eikon: Further company coverage:

  • More trends:

    Onconova Therapeutics, Inc.ONTX | OncoSec Medical IncorporatedONCS | Oncothyreon Inc.ONTY | One Horizon Group, Inc.OHGI | Oneida Financial Corp.ONFC | Onvia, Inc.ONVI | Open Text CorporationOTEX | Opexa Therapeutics, Inc.OPXA | Opexa Therapeutics, Inc.OPXAW | OpGen, Inc.OPGN |